Picato gel contains the active ingredient ingenol mebutate, which is a compound purified from the Euphorbia peplus plant. It is used to treat a skin condition called actinic keratosis.

The global Picato Gel (Ingenol Mebutate) market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Picato Gel (Ingenol Mebutate) volume and value at global level, regional level and company level. From a global perspective, this report represents overall Picato Gel (Ingenol Mebutate) market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Picato Gel (Ingenol Mebutate) in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Picato Gel (Ingenol Mebutate) manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Leo Pharma
...

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Type I
Type II

Segment by Application
Actinic Keratosis
Keratosis